26/05/25 -"We have updated our model to take on board the non-cash impairment expense of €215 million that the company accounted for in its Q1 report due to the reduced market valuation of its stake in ASMPT. ..."
Pages
51
Language
English
Published on
26/05/25
You may also be interested by these reports :
03/06/25
We have revised our forecasts downwards as the Q1 figures and a not-so-great Q2 outlook puts our previous sales target out of reach. We have reduced ...
26/05/25
We have updated our model to take on board the non-cash impairment expense of €215 million that the company accounted for in its Q1 report due to the ...
20/05/25
CMD: Lower growth expectations going forward
16/05/25
STMicroelectronics (Add; Netherlands) posted Q1 25 results largely in line with consensus expectations. The book-to-bill ratio being above 1 for both ...